Grant: Master's Award: Canada Graduate Scholarships
Université de Montréal
$17,500.00
Characterizing the Roles of Cytochrome P450 Isozymes in Breast Cancer
FY 2009-10
Summary
Breast cancer is a disease which in some cases leads to death. There are some treatments which are available to treat breast cancer, however secondary effects are present. In some cases, only partial treatment is observed and this is due to resistance to the medication. This resistance is believed to be due to the way the tumour cell defend itself against the medication. Our objective is to look at the tumour cells to determine if cytochrome P450s are responsible for the resistance to chemotherapy agents. Once identified, alternative medical treatments could be suggested.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
199669
Name
Armstrong Catherine L
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Not applicable / Specified
Prcname2
Canada Graduate Scholarships Master's Awards A
Projecttitle
Characterizing the Roles of Cytochrome P450 Isozymes in Breast Cancer
Programtype2
Studentship Programs
Orgnameinp2
Université de Montréal
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Anti-Cancer Drugs; Breast Cancer; Cancer; Cytochrome P450; Drug Metabolism; Inter-Subject Variability; Pharmacogenetics; Pharmacokinetics; Resistance; Stem Cells
Abstract
Breast cancer is a disease which in some cases leads to death. There are some treatments which are available to treat breast cancer, however secondary effects are present. In some cases, only partial treatment is observed and this is due to resistance to the medication. This resistance is believed to be due to the way the tumour cell defend itself against the medication. Our objective is to look at the tumour cells to determine if cytochrome P450s are responsible for the resistance to chemotherapy agents. Once identified, alternative medical treatments could be suggested.
Competitiondate
201002
Approvedterm2
1 yr 0 mth
Pinamesdelim
Armstrong, Catherine L
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~